PA
AERI

Pinnacle Associates’s Aerie Pharmaceuticals AERI Stock Holding History

Pinnacle Associates’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-964,759
Closed -$14.6M – 781
2022
Q3 		$14.6M Sell
964,759
-69,093
-7% -$803K 0.34% 87
2022
Q2 		$7.75M Buy
1,033,852
+2,787
+0.3% +$19.6K 0.17% 150
2022
Q1 		$9.38M Buy
1,031,065
+290,802
+39% +$2.24M 0.17% 157
2021
Q4 		$5.2M Buy
740,263
+49,984
+7% +$523K 0.09% 219
2021
Q3 		$7.87M Sell
690,279
-6,925
-1% -$101K 0.15% 167
2021
Q2 		$11.2M Buy
697,204
+8,717
+1% +$150K 0.2% 137
2021
Q1 		$12.3M Sell
688,487
-57,710
-8% -$997K 0.23% 119
2020
Q4 		$10.1M Buy
746,197
+222,137
+42% +$2.68M 0.2% 127
2020
Q3 		$6.17M Sell
524,060
-13,110
-2% -$160K 0.15% 160
2020
Q2 		$7.93M Buy
537,170
+117,447
+28% +$1.74M 0.2% 130
2020
Q1 		$5.67M Sell
419,723
-50,902
-11% -$966K 0.17% 140
2019
Q4 		$11.4M Buy
470,625
+15,875
+3% +$329K 0.25% 109
2019
Q3 		$8.74M Buy
+454,750
New +$10.4M 0.21% 132

Pinnacle Associates's AERI Position: Q4 2022 in Review

Pinnacle Associates sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 964,759 shares — an estimated $14.6M sold.

Pinnacle Associates first reported a position in AERI in Q3 2019 and held it in 13 quarters. The position peaked at $14.6M in Q3 2022. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

  • Pinnacle Associates reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Pinnacle Associates sold 964,759 Aerie Pharmaceuticals shares in Q4 2022, an estimated $14.6M.
  • Pinnacle Associates first reported a position in Aerie Pharmaceuticals in Q3 2019 and held it in 13 quarters.
  • Pinnacle Associates's Aerie Pharmaceuticals position peaked at $14.6M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on Pinnacle Associates's 13F filing for Q4 2022, filed 25 Jan 2023.